NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.
Also ASCO to release abstracts to members prior to annual meeting.
Advisors suggest NCI establish sarcoma research consortium.
Lung cancer screening trial reaches accrual goal of 50,000.
Markison leaving Bristol-Myers, two others promoted in reorganization.
Wilding named director, Univ. of Wisconsin Cancer Center.
NABCO to close June 30.
This month’s 8-page Business & Regulatory Report included in this issue.
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - From the chairs of ECOG-ACRIN: A perspective on indirect costs
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty